Here's Why I Think Every Investor Needs to Invest in These "Miracle" Drugs

GLP-1 drugs like Ozempic, Wegovy, and Mounjaro are revolutionizing healthcare with massive growth potential. Beyond weight loss and diabetes, research shows these drugs may treat cardiovascular, kidney, liver, and other diseases, with emerging evidence of anti-aging benefits. Morgan Stanley forecasts the obesity drug market will reach $190 billion by 2035, but the author believes this is understated given untapped international markets and expanding use cases.